At a glance
ClinicalIndex Comparison RecordN/ACompleted· 92 enrolled
Drug / intervention
Ceevra Revealdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Using Virtual Reality (VR) Models for Preoperative Planning
In Brief
A clinical study evaluating Ceevra Reveal for Kidney Cancer and Renal Cell Carcinoma. Completed, enrolled 92 participants across 6 sites.
Detailed Summary
A prospective, randomized, controlled study designed to assess whether digital virtual reality (VR) models, created from existing CT scans and MRIs, provide surgeons with an improved understanding of their patients' anatomy, resulting in more efficient operations (robotic partial nephrectomy) and improved patient care.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKidney Cancer, Renal Cell Carcinoma
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartOct 2017
First PostedNov 2017
Primary CompletionFeb 2019
Study CompletionMar 2019
TodayJul 2026
First PostedNov 7, 2017
Enrollment StartOct 24, 2017
Primary CompletionFeb 28, 2019
Study CompletionMar 18, 2019
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 8.7 years ago
Interventions
Ceevra Revealdevice
VR models generated using Ceevra Reveal are viewed by surgeons in connection with the case in addition to source CT/MR image.